Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Time to Progression”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05549037
What this trial is testing

Effect of Time-of-Day (ToD) for Immunochemotherapy on PFS in NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Hunan Province Tumor Hospital 210
Not applicableLooking for participantsNCT07691697
What this trial is testing

PSMA PET-Staged Comprehensive Progression-Directed Radiotherapy for Limited Progression in Prostate Cancer

Who this might be right for
Oligoprogressive Prostate CancerMetastatic Prostate Cancer
Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,000
Testing effectiveness (Phase 2)Study completedNCT01131078
What this trial is testing

Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 306
Testing effectiveness (Phase 2)Ended earlyNCT02013765
What this trial is testing

Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer

Who this might be right for
Urinary Tract Cancer
Hoffmann-La Roche 5
Not applicableUnknownNCT02577627
What this trial is testing

Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC

Who this might be right for
Non-Small Cell Lung CancerSmall Cell Lung CancerProstate Cancer+2 more
Optimata Ltd. 5,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07159191
What this trial is testing

Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell Carcinoma (aRCC)
Peking Union Medical College Hospital 30
Not applicableWithdrawnNCT00551265
What this trial is testing

Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy

Who this might be right for
Fallopian Tube CarcinomaPrimary Peritoneal CarcinomaRecurrent Ovarian Carcinoma+2 more
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT07111520
What this trial is testing

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
BioNTech SE 880
Testing effectiveness (Phase 2)Ended earlyNCT01175772
What this trial is testing

Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy

Who this might be right for
Ovarian Carcinoma
HaEmek Medical Center, Israel 6
Not applicableEnded earlyNCT02491775
What this trial is testing

Afatinib Genomic Landscape

Who this might be right for
Carcinoma, Non-Small-Cell LungNon-Small Cell Lung CancerNon-small Lung Cancer
Washington University School of Medicine 6
Post-approval studies (Phase 4)Study completedNCT02321436
What this trial is testing

Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression

Who this might be right for
StrokeUpper Limb Spasticity
Ipsen 42
Large-scale testing (Phase 3)Study completedNCT05085275
What this trial is testing

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Who this might be right for
Anemia, Iron DeficiencyHyperphosphatemiaRenal Insufficiency, Chronic+4 more
USRC Kidney Research 289
Testing effectiveness (Phase 2)Ended earlyNCT00474188
What this trial is testing

Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Celgene Corporation 26
Not applicableActive Not RecruitingNCT06480617
What this trial is testing

Observational, Bivariate Analysis of Clinical Big Data in Patients With Cervical Cancer

Who this might be right for
Progression-free Survival Was Defined From Date of Surgery to Disease Progression Post-surgery or Death or Last Follow-upOverall Survival Was Defined as Time From Surgery to Death From Any Cause or Last Follow-up
Anhui Provincial Hospital 3,000
Testing effectiveness (Phase 2)Study completedNCT00767377
What this trial is testing

Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC

Who this might be right for
Gastric Cancer
Fudan University 163
Testing effectiveness (Phase 2)Study completedNCT02103062
What this trial is testing

Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Celgene 41
Testing effectiveness (Phase 2)UnknownNCT04831658
What this trial is testing

A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Mingzhi Zhang 40
Not applicableActive Not RecruitingNCT07448662
What this trial is testing

Local Treatment Strategies for Brain Metastases of Colorectal Cancer

Who this might be right for
Colorectal CancerBrain Metastases, Adult
Blokhin's Russian Cancer Research Center 700
Large-scale testing (Phase 3)Study completedNCT01833299
What this trial is testing

Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaFace Cancer
Sun Yat-sen University 120
Not applicableStudy completedNCT02846038
What this trial is testing

Understanding Communication in Healthcare to Achieve Trust (U-CHAT)

Who this might be right for
Brain TumorsSolid Tumor
St. Jude Children's Research Hospital 138
Next Page